Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects

Neuroscience and Biobehavioral Reviews

Volumn 38, Issue , 2014, Pages 173-192

  Mahar, Ian ^a,b   Bambico, Francis Rodriguez ^c   Mechawar, Naguib ^a,b   Nobrega, José N ^c,d  

^a DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Antidepressant; Chronic unpredictable stress; Depression; Hypothalamic pituitary adrenal axis; Neurogenesis; Neurotrophic factors; Serotonin; Stress

Indexed keywords

ANTIDEPRESSANT AGENT; AUTORECEPTOR; CLOMIPRAMINE; CORTICOSTERONE; DESIPRAMINE; DOPAMINE; FLUOXETINE; IMIPRAMINE; IPSAPIRONE; MONOAMINE; NEUROTROPHIC FACTOR; NORADRENALIN; PAROXETINE; SEROTONIN 1A RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SOMATOMEDIN; TRICYCLIC ANTIDEPRESSANT AGENT; VASCULOTROPIN;

ACUTE STRESS; AFFECT; ANTIDEPRESSANT ACTIVITY; CHRONIC STRESS; DEPRESSION; DRUG RECEPTOR BINDING; ENDOPHENOTYPE; FEEDBACK SYSTEM; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MONOAMINERGIC SYSTEM; MOOD DISORDER; NERVOUS SYSTEM DEVELOPMENT; NEUROMODULATION; NEUROPATHOLOGY; NEUROTRANSMISSION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RECEPTOR DOWN REGULATION; REVIEW; SEROTONINERGIC SYSTEM; STRESS;

ANTIDEPRESSANT; CHRONIC UNPREDICTABLE STRESS; DEPRESSION; HYPOTHALAMIC-PITUITARY-ADRENAL AXIS; NEUROGENESIS; NEUROTROPHIC FACTORS; SEROTONIN; STRESS;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; DEPRESSIVE DISORDER; HIPPOCAMPUS; HUMANS; MODELS, NEUROLOGICAL; NEUROGENESIS; SEROTONIN; STRESS, PSYCHOLOGICAL;

EID: 84891625665     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2013.11.009     Document Type: Review

References (337)

1. Aberg M.A., Aberg N.D., Hedbacker H., Oscarsson J., Eriksson P.S. Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus. Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2000, 20:2896-2903.
2. Abrous D.N., Adriani W., Montaron M.F., Aurousseau C., Rougon G., Le Moal M., Piazza P.V. Nicotine self-administration impairs hippocampal plasticity. Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2002, 22:3656-3662.
3. Adachi M., Barrot M., Autry A.E., Theobald D., Monteggia L.M. Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy. Biological Psychiatry 2008, 63:642-649.
4. Ahmad A., Rasheed N., Banu N., Palit G. Alterations in monoamine levels and oxidative systems in frontal cortex, striatum, and hippocampus of the rat brain during chronic unpredictable stress. Stress 2010, 13:355-364.
5. Aimone J.B., Deng W., Gage F.H. Put them out to pastureα What are old granule cells good for, anyway..α. Hippocampus 2010, 20:1124-1125.
6. Airan R.D., Meltzer L.A., Roy M., Gong Y., Chen H., Deisseroth K. High-speed imaging reveals neurophysiological links to behavior in an animal model of depression. Science 2007, 317:819-823.
7. Akiskal H.S., Hirschfeld R.M., Yerevanian B.I. The relationship of personality to affective disorders. Archives of General Psychiatry 1983, 40:801-810.
8. Albert P.R., Benkelfat C., Descarries L. The neurobiology of depression - revisiting the serotonin hypothesis. I. Cellular and molecular mechanisms. Philosophical Transactions of the Royal Society of London. Series B, Biological sciences 2012, 367:2378-2381.
9. Allen N.B., Badcock P.B. Darwinian models of depression: a review of evolutionary accounts of mood and mood disorders. Progress in Neuropsychopharmacology & Biological Psychiatry 2006, 30:815-826.
10. Alme C.B., Buzzetti R.A., Marrone D.F., Leutgeb J.K., Chawla M.K., Schaner M.J., Bohanick J.D., Khoboko T., Leutgeb S., Moser E.I., Moser M.B., McNaughton B.L., Barnes C.A. Hippocampal granule cells opt for early retirement. Hippocampus 2010, 20:1109-1123.
11. Altar C.A., Whitehead R.E., Chen R., Wortwein G., Madsen T.M. Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biological Psychiatry 2003, 54:703-709.
12. Amat J., Aleksejev R.M., Paul E., Watkins L.R., Maier S.F. Behavioral control over shock blocks behavioral and neurochemical effects of later social defeat. Neuroscience 2010, 165:1031-1038.
13. Amat J., Baratta M.V., Paul E., Bland S.T., Watkins L.R., Maier S.F. Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus. Nature Neuroscience 2005, 8:365-371.
14. Amat J., Paul E., Watkins L.R., Maier S.F. Activation of the ventral medial prefrontal cortex during an uncontrollable stressor reproduces both the immediate and long-term protective effects of behavioral control. Neuroscience 2008, 154:1178-1186.
15. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2013, American Psychiatric Publishing, Arlington, VA. 5th ed.
16. Anacker C., Cattaneo A., Luoni A., Musaelyan K., Zunszain P.A., Milanesi E., Rybka J., Berry A., Cirulli F., Thuret S., Price J., Riva M.A., Gennarelli M., Pariante C.M. Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2013, 38:872-883.
17. Anacker C., Cattaneo A., Musaelyan K., Zunszain P.A., Horowitz M., Molteni R., Luoni A., Calabrese F., Tansey K., Gennarelli M., Thuret S., Price J., Uher R., Riva M.A., Pariante C.M. Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis. Proceedings of the National Academy of Sciences of the United States of America 2013, 110:8708-8713.
18. Anacker C., Zunszain P.A., Cattaneo A., Carvalho L.A., Garabedian M.J., Thuret S., Price J., Pariante C.M. Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor. Molecular Psychiatry 2011, 16:738-750.
19. Araneda R., Andrade R. 5-Hydroxytryptamine2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience 1991, 40:399-412.
20. Arango V., Underwood M.D., Boldrini M., Tamir H., Kassir S.A., Hsiung S., Chen J.J., Mann J.J. Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology 2001, 25:892-903.
21. Arborelius L., Hawks B.W., Owens M.J., Plotsky P.M., Nemeroff C.B. Increased responsiveness of presumed 5-HT cells to citalopram in adult rats subjected to prolonged maternal separation relative to brief separation. Psychopharmacology 2004, 176:248-255.
22. Ashby C.R., Edwards E., Wang R.Y. Electrophysiological evidence for a functional interaction between 5-HT1A and 5-HT2A receptors in the rat medial prefrontal cortex: an iontophoretic study. Synapse 1994, 17:173-181.
23. Aso E., Ozaita A., Valdizan E.M., Ledent C., Pazos A., Maldonado R., Valverde O. BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice. Journal of Neurochemistry 2008, 105:565-572.
24. Aso E., Renoir T., Mengod G., Ledent C., Hamon M., Maldonado R., Lanfumey L., Valverde O. Lack of CB1 receptor activity impairs serotonergic negative feedback. Journal of Neurochemistry 2009, 109:935-944.
25. Avgustinovich D.F., Kovalenko I.L., Kudryavtseva N.N. A model of anxious depression: persistence of behavioral pathology. Neuroscience and Behavioral Physiology 2005, 35:917-924.
26. Bambico F.R., Duranti A., Tontini A., Tarzia G., Gobbi G. Endocannabinoids in the treatment of mood disorders: evidence from animal models. Current Pharmaceutical Design 2009, 15:1623-1646.
27. Bambico F.R., Gobbi G. The cannabinoid CB1 receptor and the endocannabinoid anandamide: possible antidepressant targets. Expert Opinion on Therapeutic Targets 2008, 12:1347-1366.
28. Bambico F.R., Katz N., Debonnel G., Gobbi G. Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2007, 27:11700-11711.
29. Bambico F.R., Nguyen N.T., Gobbi G. Decline in serotonergic firing activity and desensitization of 5-HT1A autoreceptors after chronic unpredictable stress. European Neuropsychopharmacology: Journal of the European College of Neuropsychopharmacology 2009, 19:215-228.
30. Banasr M., Duman R.S. Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors. Biological Psychiatry 2008, 64:863-870.
31. Banasr M., Hery M., Printemps R., Daszuta A. Serotonin-induced increases in adult cell proliferation and neurogenesis are mediated through different and common 5-HT receptor subtypes in the dentate gyrus and the subventricular zone. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2004, 29:450-460.
32. Banasr M., Soumier A., Hery M., Mocaer E., Daszuta A. Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis. Biological Psychiatry 2006, 59:1087-1096.
33. Bannerman D.M., Rawlins J.N., McHugh S.B., Deacon R.M., Yee B.K., Bast T., Zhang W.N., Pothuizen H.H., Feldon J. Regional dissociations within the hippocampus-memory and anxiety. Neuroscience and Biobehavioral Reviews 2004, 28:273-283.
34. Barr A.M., Markou A., Phillips A.G. A 'crash' course on psychostimulant withdrawal as a model of depression. Trends in Pharmacological Sciences 2002, 23:475-482.
35. Beck K.D., Powell-Braxton L., Widmer H.R., Valverde J., Hefti F. Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron 1995, 14:717-730.
36. Bekris S., Antoniou K., Daskas S., Papadopoulou-Daifoti Z. Behavioural and neurochemical effects induced by chronic mild stress applied to two different rat strains. Behavioural Brain Research 2005, 161:45-59.
37. Belanoff J.K., Rothschild A.J., Cassidy F., DeBattista C., Baulieu E.E., Schold C., Schatzberg A.F. An open label trial of C-1073 (mifepristone) for psychotic major depression. Biological Psychiatry 2002, 52:386-392.
38. Bell C., Abrams J., Nutt D. Tryptophan depletion and its implications for psychiatry. British Journal of Psychiatry: Journal of Mental Science 2001, 178:399-405.
39. Belmaker R.H., Agam G. Major depressive disorder. New England Journal of Medicine 2008, 358:55-68.
40. Benkelfat C., Ellenbogen M.A., Dean P., Palmour R.M., Young S.N. Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disorders. Archives of General Psychiatry 1994, 51:687-697.
41. Bergstrom A., Jayatissa M.N., Mork A., Wiborg O. Stress sensitivity and resilience in the chronic mild stress rat model of depression; an in situ hybridization study. Brain Research 2008, 1196:41-52.
42. Bhagwagar Z., Rabiner E.A., Sargent P.A., Grasby P.M., Cowen P.J. Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. Molecular Psychiatry 2004, 9:386-392.
43. Bhutani M.K., Bishnoi M., Kulkarni S.K. Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes. Pharmacology, Biochemistry, and Behavior 2009, 92:39-43.
44. Bijak M., Tokarski K., Czyrak A., Mackowiak M., Wedzony K. Imipramine increases the 5-HT1A receptor-mediated inhibition of hippocampal neurons without changing the 5-HT1A receptor binding. European Journal of Pharmacology 1996, 305:79-85.
45. Billings A.G., Cronkite R.C., Moos R.H. Social-environmental factors in unipolar depression: comparisons of depressed patients and nondepressed controls. Journal of Abnormal Psychology 1983, 92:119-133.
46. Bjarkam C.R., Sorensen J.C., Geneser F.A. Distribution and morphology of serotonin-immunoreactive axons in the hippocampal region of the New Zealand white rabbit. I. Area dentata and hippocampus. Hippocampus 2003, 13:21-37.
47. Blier P., de Montigny C. Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 1999, 21:91S-98S.
48. Blier P., Pineyro G., el Mansari M., Bergeron R., de Montigny C. Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission. Annals of the New York Academy of Sciences 1998, 861:204-216.
49. Boldrini M., Hen R., Underwood M.D., Rosoklija G.B., Dwork A.J., Mann J.J., Arango V. Hippocampal angiogenesis and progenitor cell proliferation are increased with antidepressant use in major depression. Biological Psychiatry 2012, 72:562-571. 10.1016/j.biopsych.2012.04.024.
50. Boldrini M., Santiago A.N., Hen R., Dwork A.J., Rosoklija G.B., Tamir H., Arango V., Mann J.J. Hippocampal granule neuron number and dentate gyrus volume in antidepressant-treated and untreated major depression. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2013, 38:1068-1077. 10.1038/npp.2013.5.
51. Boldrini M., Underwood M.D., Hen R., Rosoklija G.B., Dwork A.J., John Mann J., Arango V. Antidepressants increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2009, 34:2376-2389.
52. Borsini F., Ceci A., Bietti G., Donetti A. BIMT 17, a 5-HT1A receptor agonist/5-HT2A receptor antagonist, directly activates postsynaptic 5-HT inhibitory responses in the rat cerebral cortex. Naunyn-Schmiedeberg's Archives of Pharmacology 1995, 352:283-290.
53. Bosker F.J., Klompmakers A., Westenberg H.G. Postsynaptic 5-HT1A receptors mediate 5-hydroxytryptamine release in the amygdala through a feedback to the caudal linear raphe. European Journal of Pharmacology 1997, 333:147-157.
54. Branchi I., Santarelli S., Capoccia S., Poggini S., D'Andrea I., Cirulli F., Alleva E. Antidepressant treatment outcome depends on the quality of the living environment: a pre-clinical investigation in mice. PLoS ONE 2013, 8:e62226.
55. Brenes Saenz J.C., Villagra O.R., Fornaguera Trias J. Factor analysis of forced swimming test, sucrose preference test and open field test on enriched, social and isolated reared rats. Behavioural Brain Research 2006, 169:57-65.
56. Brezun J.M., Daszuta A. Serotonergic reinnervation reverses lesion-induced decreases in PSA-NCAM labeling and proliferation of hippocampal cells in adult rats. Hippocampus 2000, 10:37-46.
57. Brezun J.M., Daszuta A. Serotonin may stimulate granule cell proliferation in the adult hippocampus, as observed in rats grafted with foetal raphe neurons. European Journal of Neuroscience 2000, 12:391-396.
58. Broadbent N.J., Gaskin S., Squire L.R., Clark R.E. Object recognition memory and the rodent hippocampus. Learning & Memory 2010, 17:5-11.
59. Brown E.S., Varghese F.P., McEwen B.S. Association of depression with medical illness: does cortisol play a roleα. Biological Psychiatry 2004, 55:1-9.
60. Brummelte S., Galea L.A. Chronic high corticosterone reduces neurogenesis in the dentate gyrus of adult male and female rats. Neuroscience 2010, 168:680-690.
61. Cai X., Gu Z., Zhong P., Ren Y., Yan Z. Serotonin 5-HT1A receptors regulate AMPA receptor channels through inhibiting Ca2+/calmodulin-dependent kinase II in prefrontal cortical pyramidal neurons. Journal of Biological Chemistry 2002, 277:36553-36562.
62. Carlsson T., Schindler F.R., Hollerhage M., Depboylu C., Arias-Carrion O., Schnurrbusch S., Rosler T.W., Wozny W., Schwall G.P., Groebe K., Oertel W.H., Brundin P., Schrattenholz A., Hoglinger G.U. Systemic administration of neuregulin-1beta1 protects dopaminergic neurons in a mouse model of Parkinson's disease. Journal of Neurochemistry 2011, 117:1066-1074.
63. Caspi A., Hariri A.R., Holmes A., Uher R., Moffitt T.E. Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. American Journal of Psychiatry 2010, 167:509-527.
64. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., McClay J., Mill J., Martin J., Braithwaite A., Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003, 301:386-389.
65. Celada P., Puig M.V., Casanovas J.M., Guillazo G., Artigas F. Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: Involvement of serotonin-1A, GABA(A), and glutamate receptors. Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2001, 21:9917-9929.
66. Chiba S., Numakawa T., Ninomiya M., Richards M.C., Wakabayashi C., Kunugi H. Chronic restraint stress causes anxiety- and depression-like behaviors, downregulates glucocorticoid receptor expression, and attenuates glutamate release induced by brain-derived neurotrophic factor in the prefrontal cortex. Progress in Neuropsychopharmacology & Biological Psychiatry 2012, 39:112-119.
67. Christiansen S., Bouzinova E.V., Palme R., Wiborg O. Circadian activity of the hypothalamic-pituitary-adrenal axis is differentially affected in the rat chronic mild stress model of depression. Stress 2012, 15:647-657.
68. Commons K.G. Evidence for topographically organized endogenous 5-HT-1A receptor-dependent feedback inhibition of the ascending serotonin system. European Journal of Neuroscience 2008, 27:2611-2618.
69. Cowen P.J., Power A.C., Ware C.J., Anderson I.M. 5-HT1A receptor sensitivity in major depression. A neuroendocrine study with buspirone. British Journal of Psychiatry 1994, 164:372-379.
70. Crawford L.K., Craige C.P., Beck S.G. Increased intrinsic excitability of lateral wing serotonin neurons of the dorsal raphe: a mechanism for selective activation in stress circuits. Journal of Neurophysiology 2010, 103:2652-2663.
71. Crespi F. Apamin increases 5-HT cell firing in raphe dorsalis and extracellular 5-HT levels in amygdala: a concomitant in vivo study in anesthetized rats. Brain Research 2009, 1281:35-46.
72. Crespi F. SK channel blocker apamin attenuates the effect of SSRI fluoxetine upon cell firing in dorsal raphe nucleus: a concomitant electrophysiological and electrochemical in vivo study reveals implications for modulating extracellular 5-HT. Brain Research 2010, 1334:1-11.
73. Cryan J.F., Holmes A. The ascent of mouse: advances in modelling human depression and anxiety. Nature Reviews. Drug Discovery 2005, 4:775-790.
74. Czubak A., Nowakowska E., Kus K., Burda K., Metelska J., Baer-Dubowska W., Cichocki M. Influences of chronic venlafaxine, olanzapine and nicotine on the hippocampal and cortical concentrations of brain-derived neurotrophic factor (BDNF). Pharmacological Reports 2009, 61:1017-1023.
75. Dagyte G., Crescente I., Postema F., Seguin L., Gabriel C., Mocaer E., Boer J.A., Koolhaas J.M. Agomelatine reverses the decrease in hippocampal cell survival induced by chronic mild stress. Behavioural Brain Research 2011, 218:121-128.
76. Dagyte G., Trentani A., Postema F., Luiten P.G., Den Boer J.A., Gabriel C., Mocaer E., Meerlo P., Van der Zee E.A. The novel antidepressant agomelatine normalizes hippocampal neuronal activity and promotes neurogenesis in chronically stressed rats. CNS Neuroscience & Therapeutics 2010, 16:195-207.
77. Dahlstroem A., Fuxe K. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiologica Scandinavica. Supplementum 1964, (Suppl. 232):231-255.
78. Dang H., Chen Y., Liu X., Wang Q., Wang L., Jia W., Wang Y. Antidepressant effects of ginseng total saponins in the forced swimming test and chronic mild stress models of depression. Progress in Neuropsychopharmacology & Biological Psychiatry 2009, 33:1417-1424.
79. Dang H., Sun L., Liu X., Peng B., Wang Q., Jia W., Chen Y., Pan A., Xiao P. Preventive action of Kai Xin San aqueous extract on depressive-like symptoms and cognition deficit induced by chronic mild stress. Experimental Biology and Medicine 2009, 234:785-793.
80. David D.J., Samuels B.A., Rainer Q., Wang J.W., Marsteller D., Mendez I., Drew M., Craig D.A., Guiard B.P., Guilloux J.P., Artymyshyn R.P., Gardier A.M., Gerald C., Antonijevic I.A., Leonardo E.D., Hen R. Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 2009, 62:479-493.
81. De Montigny C. Enhancement of the 5-HT neurotransmission by antidepressant treatments. Journal de Physiologie 1981, 77:455-461.
82. Delgado P.L., Miller H.L., Salomon R.M., Licinio J., Krystal J.H., Moreno F.A., Heninger G.R., Charney D.S. Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action. Biological Psychiatry 1999, 46:212-220.
83. Deng W., Aimone J.B., Gage F.H. New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memoryα. Nature Reviews. Neuroscience 2010, 11:339-350.
84. Descarries L., Watkins K.C., Garcia S., Beaudet A. The serotonin neurons in nucleus raphe dorsalis of adult rat: a light and electron microscope radioautographic study. Journal of Comparative Neurology 1982, 207:239-254.
85. Diaz S.L., Doly S., Narboux-Neme N., Fernandez S., Mazot P., Banas S.M., Boutourlinsky K., Moutkine I., Belmer A., Roumier A., Maroteaux L. 5-HT2B receptors are required for serotonin-selective antidepressant actions. Molecular Psychiatry 2012, 17:154-163.
86. Dranovsky A., Hen R. Hippocampal neurogenesis: regulation by stress and antidepressants. Biological Psychiatry 2006, 59:1136-1143.
87. Drevets W.C., Thase M.E., Moses-Kolko E.L., Price J., Frank E., Kupfer D.J., Mathis C. Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nuclear Medicine and Biology 2007, 34:865-877.
88. Dulawa S.C., Hen R. Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test. Neuroscience and Biobehavioral Reviews 2005, 29:771-783.
89. Duman C.H., Schlesinger L., Terwilliger R., Russell D.S., Newton S.S., Duman R.S. Peripheral insulin-like growth factor-I produces antidepressant-like behavior and contributes to the effect of exercise. Behavioural Brain Research 2009, 198:366-371.
90. Duric V., Banasr M., Stockmeier C.A., Simen A.A., Newton S.S., Overholser J.C., Jurjus G.J., Dieter L., Duman R.S. Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects. The International Journal of Neuropsychopharmacology/Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum 2013, 16:69-82.
91. Egeland M., Zhang X., Millan M.J., Mocaer E., Svenningsson P. Pharmacological or genetic blockade of the dopamine D3 receptor increases cell proliferation in the hippocampus of adult mice. Journal of Neurochemistry 2012, 123:811-823.
92. Eisch A.J., Petrik D. Depression and hippocampal neurogenesis: a road to remissionα. Science 2012, 338:72-75.
93. El Hage W., Powell J.F., Surguladze S.A. Vulnerability to depression: what is the role of stress genes in gene×environment interactionα. Psychological Medicine 2009, 39:1407-1411.
94. Elizalde N., Garcia-Garcia A.L., Totterdell S., Gendive N., Venzala E., Ramirez M.J., Del Rio J., Tordera R.M. Sustained stress-induced changes in mice as a model for chronic depression. Psychopharmacology 2010, 210:393-406.
95. Eriksson P.S., Perfilieva E., Bjork-Eriksson T., Alborn A.M., Nordborg C., Peterson D.A., Gage F.H. Neurogenesis in the adult human hippocampus. Nature Medicine 1998, 4:1313-1317.
96. Fabre V., Beaufour C., Evrard A., Rioux A., Hanoun N., Lesch K.P., Murphy D.L., Lanfumey L., Hamon M., Martres M.P. Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter. European Journal of Neuroscience 2000, 12:2299-2310.
97. Fairbank J.A., Hansen D.J., Fitterling J.M. Patterns of appraisal and coping across different stressor conditions among former prisoners of war with and without posttraumatic stress disorder. Journal of Consulting and Clinical Psychology 1991, 59:274-281.
98. Fanselow M.S., Dong H.W. Are the dorsal and ventral hippocampus functionally distinct structuresα. Neuron 2010, 65:7-19.
99. Feldmann R.E., Sawa A., Seidler G.H. Causality of stem cell based neurogenesis and depression - to be or not to be, is that the questionα. Journal of Psychiatric Research 2007, 41:713-723.
100. Ferland C.L., Schrader L.A. Regulation of histone acetylation in the hippocampus of chronically stressed rats: a potential role of sirtuins. Neuroscience 2011, 174:104-114.
101. Ferres-Coy A., Pilar-Cuellar F., Vidal R., Paz V., Masana M., Cortes R., Carmona M.C., Campa L., Pazos A., Montefeltro A., Valdizan E.M., Artigas F., Bortolozzi A. RNAi-mediated serotonin transporter suppression rapidly increases serotonergic neurotransmission and hippocampal neurogenesis. Translational Psychiatry 2013, 3:e211.
102. Firk C., Markus C.R. Review: serotonin by stress interaction: a susceptibility factor for the development of depressionα. Journal of Psychopharmacology 2007, 21:538-544.
103. Fitzsimons C.P., van Hooijdonk L.W., Morrow J.A., Peeters B.W., Hamilton N., Craighead M., Vreugdenhil E. Antiglucocorticoids, neurogenesis and depression. Mini Reviews in Medicinal Chemistry 2009, 9:249-264.
104. Flores B.H., Kenna H., Keller J., Solvason H.B., Schatzberg A.F. Clinical and biological effects of mifepristone treatment for psychotic depression. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2006, 31:628-636.
105. Froger N., Palazzo E., Boni C., Hanoun N., Saurini F., Joubert C., Dutriez-Casteloot I., Enache M., Maccari S., Barden N., Cohen-Salmon C., Hamon M., Lanfumey L. Neurochemical and behavioral alterations in glucocorticoid receptor-impaired transgenic mice after chronic mild stress. Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2004, 24:2787-2796.
106. Gabbott P.L.A., Warner T.A., Jays P.R.L., Salway P., Busby S.J. Prefrontal cortex in the rat: projections to subcortical autonomic, motor, and limbic centers. Journal of Comparative Neurology 2005, 492:145-177.
107. Gage F.H., Thompson R.G. Differential distribution of norepinephrine and serotonin along the dorsal-ventral axis of the hippocampal formation. Brain Research Bulletin 1980, 5:771-773.
108. Gartside S.E., Hajos-Korcsok E., Bagdy E., Harsing L.G., Sharp T., Hajos M. Neurochemical and electrophysiological studies on the functional significance of burst firing in serotonergic neurons. Neuroscience 2000, 98:295-300.
109. Gartside S.E., Leitch M.M., Young A.H. Altered glucocorticoid rhythm attenuates the ability of a chronic SSRI to elevate forebrain 5-HT: implications for the treatment of depression. Neuropsychopharmacology 2003, 28:1572-1578.
110. Gasbarri A., Verney C., Innocenzi R., Campana E., Pacitti C. Mesolimbic dopaminergic neurons innervating the hippocampal formation in the rat: a combined retrograde tracing and immunohistochemical study. Brain Research 1994, 668:71-79.
111. Ge S., Yang C.H., Hsu K.S., Ming G.L., Song H. A critical period for enhanced synaptic plasticity in newly generated neurons of the adult brain. Neuron 2007, 54:559-566.
112. Gersner R., Toth E., Isserles M., Zangen A. Site-specific antidepressant effects of repeated subconvulsive electrical stimulation: potential role of brain-derived neurotrophic factor. Biological Psychiatry 2010, 67:125-132.
113. Glasper E.R., Llorens-Martin M.V., Leuner B., Gould E., Trejo J.L. Blockade of insulin-like growth factor-I has complex effects on structural plasticity in the hippocampus. Hippocampus 2010, 20:706-712.
114. Gobbi G., Murphy D.L., Lesch K., Blier P. Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study. Journal of Pharmacology and Experimental Therapeutics 2001, 296:987-995.
115. Goldstein G., Fava M., Culler M., Fisher A., Rickels K., Lydiard R.B., Rosenbaum J. Elevated plasma thymopoietin associated with therapeutic nonresponsiveness in major depression. Biological Psychiatry 2000, 48:65-69.
116. Grahn R.E., Will M.J., Hammack S.E., Maswood S., McQueen M.B., Watkins L.R., Maier S.F. Activation of serotonin-immunoreactive cells in the dorsal raphe nucleus in rats exposed to an uncontrollable stressor. Brain Research 1999, 826:35-43.
117. Gray N.A., Milak M.S., DeLorenzo C., Ogden R.T., Huang Y.Y., Mann J.J., Parsey R.V. Antidepressant treatment reduces serotonin-1A autoreceptor binding in major depressive disorder. Biological Psychiatry 2013, 74:26-31.
118. Grippo A.J., Beltz T.G., Weiss R.M., Johnson A.K. The effects of chronic fluoxetine treatment on chronic mild stress-induced cardiovascular changes and anhedonia. Biological Psychiatry 2006, 59:309-316.
119. Grippo A.J., Sullivan N.R., Damjanoska K.J., Crane J.W., Carrasco G.A., Shi J., Chen Z., Garcia F., Muma N.A., Van de Kar L.D. Chronic mild stress induces behavioral and physiological changes, and may alter serotonin 1A receptor function, in male and cycling female rats. Psychopharmacology 2005, 179:769-780.
120. Guiard B.P., El Mansari M., Blier P. Cross-talk between dopaminergic and noradrenergic systems in the rat ventral tegmental area, locus ceruleus, and dorsal hippocampus. Molecular Pharmacology 2008, 74:1463-1475.
121. Guiard B.P., El Mansari M., Merali Z., Blier P. Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions. The International Journal of Neuropsychopharmacology/Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum 2008, 11:625-639.
122. Hajos M., Hajos-Korcsok E., Sharp T. Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat. British Journal of Pharmacology 1999, 126:1741-1750.
123. Hale M.W., Hay-Schmidt A., Mikkelsen J.D., Poulsen B., Bouwknecht J.A., Evans A.K., Stamper C.E., Shekhar A., Lowry C.A. Exposure to an open-field arena increases c-Fos expression in a subpopulation of neurons in the dorsal raphe nucleus, including neurons projecting to the basolateral amygdaloid complex. Neuroscience 2008, 157:733-748.
124. Hall H., Lundkvist C., Halldin C., Farde L., Pike V.W., McCarron J.A., Fletcher A., Cliffe I.A., Barf T., Wikstrom H., Sedvall G. Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635. Brain Research 1997, 745:96-108.
125. Hamani C., Diwan M., Isabella S., Lozano A.M., Nobrega J.N. Effects of different stimulation parameters on the antidepressant-like response of medial prefrontal cortex deep brain stimulation in rats. Journal of Psychiatric Research 2010, 44:683-687.
126. Hamani C., Diwan M., Macedo C.E., Brandao M.L., Shumake J., Gonzalez-Lima F., Raymond R., Lozano A.M., Fletcher P.J., Nobrega J.N. Antidepressant-like effects of medial prefrontal cortex deep brain stimulation in rats. Biological Psychiatry 2010, 67:117-124.
127. Hanson N.D., Owens M.J., Nemeroff C.B. Depression, antidepressants, and neurogenesis: a critical reappraisal. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2011, 36:2589-2602.
128. Harkin A., Kelly J.P., Leonard B.E. A review of the relevance and validity of olfactory bulbectomy as a model of depression. Clinical Neuroscience Research 2003, 3:253-262.
129. Hasler G. Pathophysiology of depression: do we have any solid evidence of interest to cliniciansα. World Psychiatry 2010, 9:155-161.
130. Henningsen K., Palmfeldt J., Christiansen S., Baiges I., Bak S., Jensen O.N., Gregersen N., Wiborg O. Candidate hippocampal biomarkers of susceptibility and resilience to stress in a rat model of depression. Molecular & Cellular Proteomics 2012, MCP 11. M111 016428.
131. Hervas I., Artigas F. Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors. European Journal of Pharmacology 1998, 358:9-18.
132. Heym J., Trulson M.E., Jacobs B.L. Raphe unit activity in freely moving cats: effects of phasic auditory and visual stimuli. Brain Research 1982, 232:29-39.
133. Hill M.N., Hillard C.J., Bambico F.R., Patel S., Gorzalka B.B., Gobbi G. The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants. Trends in Pharmacological Sciences 2009, 30:484-493.
134. Hirvonen J., Karlsson H., Kajander J., Lepola A., Markkula J., Rasi-Hakala H., Nagren K., Salminen J.K., Hietala J. Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635. International Journal of Neuropsychopharmacology 2008, 11:465-476.
135. Hobin J.A., Ji J., Maren S. Ventral hippocampal muscimol disrupts context-specific fear memory retrieval after extinction in rats. Hippocampus 2006, 16:174-182.
136. Hoglinger G.U., Rizk P., Muriel M.P., Duyckaerts C., Oertel W.H., Caille I., Hirsch E.C. Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nature Neuroscience 2004, 7:726-735.
137. Holderbach R., Clark K., Moreau J.-L., Bischofberger J., Normann C. Enhanced long-term synaptic depression in an animal model of depression. Biological Psychiatry 2007, 62:92-9100.
138. Holick K.A., Lee D.C., Hen R., Dulawa S.C. Behavioral effects of chronic fluoxetine in BALB/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2008, 33:406-417.
139. Holmes A. Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease. Neuroscience and Biobehavioral Reviews 2008, 32:1293-1314.
140. Huang G.J., Bannerman D., Flint J. Chronic fluoxetine treatment alters behavior, but not adult hippocampal neurogenesis, in BALB/cJ mice. Molecular Psychiatry 2008, 13:119-121.
141. Jacobs B.L., van Praag H., Gage F.H. Adult brain neurogenesis and psychiatry: a novel theory of depression. Molecular Psychiatry 2000, 5:262-269.
142. Jacobs N., Kenis G., Peeters F., Derom C., Vlietinck R., van Os J. Stress-related negative affectivity and genetically altered serotonin transporter function: evidence of synergism in shaping risk of depression. Archives of General Psychiatry 2006, 63:989-996.
143. Jans L.A., Riedel W.J., Markus C.R., Blokland A. Serotonergic vulnerability and depression: assumptions, experimental evidence and implications. Molecular Psychiatry 2007, 12:522-543.
144. Jayatissa M.N., Bisgaard C., Tingstrom A., Papp M., Wiborg O. Hippocampal cytogenesis correlates to escitalopram-mediated recovery in a chronic mild stress rat model of depression. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2006, 31:2395-2404.
145. Jayatissa M.N., Bisgaard C.F., West M.J., Wiborg O. The number of granule cells in rat hippocampus is reduced after chronic mild stress and re-established after chronic escitalopram treatment. Neuropharmacology 2008, 54:530-541.
146. Jayatissa M.N., Henningsen K., West M.J., Wiborg O. Decreased cell proliferation in the dentate gyrus does not associate with development of anhedonic-like symptoms in rats. Brain Research 2009, 1290:133-141.
147. Jhaveri D.J., Mackay E.W., Hamlin A.S., Marathe S.V., Nandam L.S., Vaidya V.A., Bartlett P.F. Norepinephrine directly activates adult hippocampal precursors via beta3-adrenergic receptors. Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2010, 30:2795-2806.
148. Jiang W., Zhang Y., Xiao L., Van Cleemput J., Ji S.P., Bai G., Zhang X. Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. Journal of Clinical Investigation 2005, 115:3104-3116.
149. Jin K., Zhu Y., Sun Y., Mao X.O., Xie L., Greenberg D.A. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:11946-11950.
150. Juckel G., Mendlin A., Jacobs B.L. Electrical stimulation of rat medial prefrontal cortex enhances forebrain serotonin output: implications for electroconvulsive therapy and transcranial magnetic stimulation in depression. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 1999, 21:391-398.
151. Judd L.L., Akiskal H.S., Maser J.D., Zeller P.J., Endicott J., Coryell W., Paulus M.P., Kunovac J.L., Leon A.C., Mueller T.I., Rice J.A., Keller M.B. Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. Journal of Affective Disorders 1998, 50:97-108.
152. Kang M., Pyun K.H., Jang C.G., Kim H., Bae H., Shim I. Nelumbinis Semen reverses a decrease in hippocampal 5-HT release induced by chronic mild stress in rats. Journal of Pharmacy and Pharmacology 2005, 57:651-656.
153. Karg K., Burmeister M., Shedden K., Sen S. The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Archives of General Psychiatry 2011, 68:444-454.
154. Kastin A.J., Akerstrom V., Pan W. Neuregulin-1-beta1 enters brain and spinal cord by receptor-mediated transport. Journal of Neurochemistry 2004, 88:965-970.
155. Kaufman J., Yang B.Z., Douglas-Palumberi H., Houshyar S., Lipschitz D., Krystal J.H., Gelernter J. Social supports and serotonin transporter gene moderate depression in maltreated children. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:17316-17321.
156. Keller M.C., Neale M.C., Kendler K.S. Association of different adverse life events with distinct patterns of depressive symptoms. American Journal of Psychiatry 2007, 164:1521-1529.
157. Kempermann G. Regulation of adult hippocampal neurogenesis - implications for novel theories of major depression. Bipolar Disorders 2002, 4:17-33.
158. Kempermann G. Adult Neurogenesis 2 2011, Oxford University Press, New York, NY. 2nd ed.
159. Kempermann G., Kronenberg G. Depressed new neurons - adult hippocampal neurogenesis and a cellular plasticity hypothesis of major depression. Biological Psychiatry 2003, 54:499-503.
160. Kendler K.S., Gardner C.O., Prescott C.A. Toward a comprehensive developmental model for major depression in women. American Journal of Psychiatry 2002, 159:1133-1145.
161. Kendler K.S., Gardner C.O., Prescott C.A. Toward a comprehensive developmental model for major depression in men. American Journal of Psychiatry 2006, 163:115-124.
162. Kendler K.S., Kessler R.C., Walters E.E., MacLean C., Neale M.C., Heath A.C., Eaves L.J. Stressful life events, genetic liability, and onset of an episode of major depression in women. American Journal of Psychiatry 1995, 152:833-842.
163. Kendler K.S., Kuhn J.W., Prescott C.A. Childhood sexual abuse, stressful life events and risk for major depression in women. Psychological Medicine 2004, 34:1475-1482.
164. Kendler K.S., Kuhn J.W., Vittum J., Prescott C.A., Riley B. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Archives of General Psychiatry 2005, 62:529-535.
165. Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., Rush A.J., Walters E.E., Wang P.S., National Comorbidity Survey R. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA: Journal of the American Medical Association 2003, 289:3095-3105.
166. Kheirbek M.A., Hen R. Dorsal vs ventral hippocampal neurogenesis: implications for cognition and mood. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2011, 36:373-374.
167. Kim H., Whang W.W., Kim H.T., Pyun K.H., Cho S.Y., Hahm D.H., Lee H.J., Shim I. Expression of neuropeptide Y and cholecystokinin in the rat brain by chronic mild stress. Brain Research 2003, 983:201-208.
168. Kinney G.G., Vogel G.W., Feng P. Decreased dorsal raphe nucleus neuronal activity in adult chloral hydrate anesthetized rats following neonatal clomipramine treatment: implications for endogenous depression. Brain Research 1997, 756:68-75.
169. Kiuchi T., Lee H., Mikami T. Regular exercise cures depression-like behavior via VEGF-Flk-1 signaling in chronically stressed mice. Neuroscience 2012, 207:208-217.
170. Kiyasova V., Bonnavion P., Scotto-Lomassese S., Fabre V., Sahly I., Tronche F., Deneris E., Gaspar P., Fernandez S.P. A subpopulation of serotonergic neurons that do not express the 5-HT1A autoreceptor. ACS Chemical Neuroscience 2013, 4:89-95.
171. Kjelstrup K.G., Tuvnes F.A., Steffenach H.A., Murison R., Moser E.I., Moser M.B. Reduced fear expression after lesions of the ventral hippocampus. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:10825-10830.
172. Klaassen T., Riedel W.J., Deutz N.E., van Someren A., van Praag H.M. Specificity of the tryptophan depletion method. Psychopharmacology 1999, 141:279-286.
173. Klaassen T., Riedel W.J., van Someren A., Deutz N.E., Honig A., van Praag H.M. Mood effects of 24-hour tryptophan depletion in healthy first-degree relatives of patients with affective disorders. Biological Psychiatry 1999, 46:489-497.
174. Kobayashi K., Ikeda Y., Sakai A., Yamasaki N., Haneda E., Miyakawa T., Suzuki H. Reversal of hippocampal neuronal maturation by serotonergic antidepressants. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:8434-8439.
175. Kohler S.J., Williams N.I., Stanton G.B., Cameron J.L., Greenough W.T. Maturation time of new granule cells in the dentate gyrus of adult macaque monkeys exceeds six months. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:10326-10331.
176. Kulkarni V.A., Jha S., Vaidya V.A. Depletion of norepinephrine decreases the proliferation, but does not influence the survival and differentiation, of granule cell progenitors in the adult rat hippocampus. European Journal of Neuroscience 2002, 16:2008-2012.
177. Laaris N., Le Poul E., Hamon M., Lanfumey L. Stress-induced alterations of somatodendritic 5-HT1A autoreceptor sensitivity in the rat dorsal raphe nucleus - in vitro electrophysiological evidence. Fundamental & Clinical Pharmacology 1997, 11:206-214.
178. Lan M.J., Hesselgrave N., Ciarleglio A., Ogden R.T., Sullivan G.M., Mann J.J., Parsey R.V. Higher pretreatment 5-HT1A receptor binding potential in bipolar disorder depression is associated with treatment remission: a naturalistic treatment pilot PET study. Synapse 2013, 67:773-778.
179. Lanfumey L., Mongeau R., Cohen-Salmon C., Hamon M. Corticosteroid-serotonin interactions in the neurobiological mechanisms of stress-related disorders. Neuroscience and Biobehavioral Reviews 2008, 32:1174-1184.
180. Lanfumey L., Pardon M.C., Laaris N., Joubert C., Hanoun N., Hamon M., Cohen-Salmon C. 5-HT1A autoreceptor desensitization by chronic ultramild stress in mice. Neuroreport 1999, 10:3369-3374.
181. Larsen M.H., Mikkelsen J.D., Hay-Schmidt A., Sandi C. Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment. Journal of Psychiatric Research 2010, 44:808-816.
182. Le Francois B., Czesak M., Steubl D., Albert P.R. Transcriptional regulation at a HTR1A polymorphism associated with mental illness. Neuropharmacology 2008, 55:977-985.
183. Le Poul E., Laaris N., Hamon M., Lanfumey L. Fluoxetine-induced desensitization of somatodendritic 5-HT1A autoreceptors is independent of glucocorticoid(s). Synapse 1997, 27:303-312.
184. Lee Y.S., Liu F., Segil N. A morphogenetic wave of p27Kip1 transcription directs cell cycle exit during organ of Corti development. Development 2006, 133:2817-2826.
185. Lesch K.P. Gene-environment interaction and the genetics of depression. Journal of Psychiatry & Neuroscience 2004, 29:174-184.
186. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Muller C.R., Hamer D.H., Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274:1527-1531.
187. Leussis M.P., Freund N., Brenhouse H.C., Thompson B.S., Andersen S.L. Depressive-like behavior in adolescents after maternal separation: sex differences, controllability, and GABA. Developmental Neuroscience 2012, 34:210-217.
188. Levinson D.F. The genetics of depression: a review. Biological Psychiatry 2006, 60:84-92.
189. Leyton M., Ghadirian A.M., Young S.N., Palmour R.M., Blier P., Helmers K.F., Benkelfat C. Depressive relapse following acute tryptophan depletion in patients with major depressive disorder. Journal of Psychopharmacology 2000, 14:284-287.
190. Li Q., Wichems C., Heils A., Lesch K.P., Murphy D.L. Reduction in the density and expression, but not G-protein coupling, of serotonin receptors (5-HT1A) in 5-HT transporter knock-out mice: gender and brain region differences. Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2000, 20:7888-7895.
191. Li Y.F., Zhang Y.Z., Liu Y.Q., Wang H.L., Yuan L., Luo Z.P. Moclobemide up-regulates proliferation of hippocampal progenitor cells in chronically stressed mice. Acta Pharmacologica Sinica 2004, 25:1408-1412.
192. Lira A., Zhou M., Castanon N., Ansorge M.S., Gordon J.A., Francis J.H., Bradley-Moore M., Lira J., Underwood M.D., Arango V., Kung H.F., Hofer M.A., Hen R., Gingrich J.A. Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biological Psychiatry 2003, 54:960-971.
193. Lucki I. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behavioural Pharmacology 1997, 8:523-532.
194. Luo D.D., An S.C., Zhang X. Involvement of hippocampal serotonin and neuropeptide Y in depression induced by chronic unpredicted mild stress. Brain Research Bulletin 2008, 77:8-12.
195. Lupien S.J., McEwen B.S., Gunnar M.R., Heim C. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nature Reviews. Neuroscience 2009, 10:434-445.
196. Mahar I., Bagot R.C., Davoli M.A., Miksys S., Tyndale R.F., Walker C.D., Maheu M., Huang S.H., Wong T.P., Mechawar N. Developmental hippocampal neuroplasticity in a model of nicotine replacement therapy during pregnancy and breastfeeding. PLoS ONE 2012, 7:e37219.
197. Mahar I., Tan S., Davoli M.A., Dominguez-Lopez S., Qiang C., Rachalski A., Turecki G., Mechawar N. Subchronic peripheral neuregulin-1 increases ventral hippocampal neurogenesis and induces antidepressant-like effects. PLoS ONE 2011, 6:e26610.
198. Maier S.F., Amat J., Baratta M.V., Paul E., Watkins L.R. Behavioral control, the medial prefrontal cortex, and resilience. Dialogues in Clinical Neuroscience 2006, 8:397-406.
199. Maier S.F., Watkins L.R. Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. Neuroscience and Biobehavioral Reviews 2005, 29:829-841.
200. Malberg J.E., Duman R.S. Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2003, 28:1562-1571.
201. Malberg J.E., Eisch A.J., Nestler E.J., Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2000, 20:9104-9110.
202. Mann J.J., Huang Y.Y., Underwood M.D., Kassir S.A., Oppenheim S., Kelly T.M., Dwork A.J., Arango V. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Archives of General Psychiatry 2000, 57:729-738.
203. Martin-Ruiz R., Puig M.V., Celada P., Shapiro D.A., Roth B.L., Mengod G., Artigas F. Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism. Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2001, 21:9856-9866.
204. Martin-Ruiz R., Ugedo L. Electrophysiological evidence for postsynaptic 5-HT(1A) receptor control of dorsal raphe 5-HT neurones. Neuropharmacology 2001, 41:72-78.
205. Masuda T., Nakagawa S., Boku S., Nishikawa H., Takamura N., Kato A., Inoue T., Koyama T. Noradrenaline increases neural precursor cells derived from adult rat dentate gyrus through beta2 receptor. Progress in Neuropsychopharmacology & Biological Psychiatry 2012, 36:44-51.
206. Maudhuit C., Hamon M., Adrien J. Electrophysiological activity of raphe dorsalis serotoninergic neurones in a possible model of endogenous depression. Neuroreport 1995, 6:681-684.
207. Maudhuit C., Hamon M., Adrien J. Effects of chronic treatment with zimelidine and REM sleep deprivation on the regulation of raphe neuronal activity in a rat model of depression. Psychopharmacology 1996, 124:267-274.
208. Mayberg H.S., Lozano A.M., Voon V., McNeely H.E., Seminowicz D., Hamani C., Schwalb J.M., Kennedy S.H. Deep brain stimulation for treatment-resistant depression. Neuron 2005, 45:651-660.
209. McArthur R., Borsini F. Animal models of depression in drug discovery: a historical perspective. Pharmacology, Biochemistry, and Behavior 2006, 84:436-452.
210. McGrath P.J., Khan A.Y., Trivedi M.H., Stewart J.W., Morris D.W., Wisniewski S.R., Miyahara S., Nierenberg A.A., Fava M., Rush A.J. Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report. Journal of Clinical Psychiatry 2008, 69:1847-1855.
211. Meltzer C.C., Price J.C., Mathis C.A., Butters M.A., Ziolko S.K., Moses-Kolko E., Mazumdar S., Mulsant B.H., Houck P.R., Lopresti B.J., Weissfeld L.A., Reynolds C.F. Serotonin 1A receptor binding and treatment response in late-life depression. Neuropsychopharmacology 2004, 29:2258-2265.
212. Menke A., Klengel T., Binder E.B. Epigenetics, depression and antidepressant treatment. Current Pharmaceutical Design 2012, 18:5879-5889.
213. Miller J.M., Hesselgrave N., Ogden R.T., Zanderigo F., Oquendo M.A., Mann J.J., Parsey R.V. Brain serotonin 1A receptor binding as a predictor of treatment outcome in major depressive disorder. Biological Psychiatry 2013, 74:760-767.
214. Mineur Y.S., Belzung C., Crusio W.E. Functional implications of decreases in neurogenesis following chronic mild stress in mice. Neuroscience 2007, 150:251-259.
215. Mo B., Feng N., Renner K., Forster G. Restraint stress increases serotonin release in the central nucleus of the amygdala via activation of corticotropin-releasing factor receptors. Brain Research Bulletin 2008, 76:493-498.
216. Monroe S.M., Simons A.D. Diathesis-stress theories in the context of life stress research: implications for the depressive disorders. Psychological Bulletin 1991, 110:406-425.
217. Moreau J.L., Jenck F., Martin J.R., Mortas P., Haefely W.E. Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behavior in rats. European Neuropsychopharmacology: Journal of the European College of Neuropsychopharmacology 1992, 2:43-49.
218. Moreau J.L., Scherschlicht R., Jenck F., Martin J.R. Chronic mild stress-induced anhedonia model of depression; sleep abnormalities and curative effects of electroshock treatment. Behavioural Pharmacology 1995, 6:682-687.
219. Mosko S.S., Jacobs B.L. Midbrain raphe neurons: spontaneous activity and response to light. Physiology & Behavior 1974, 13:589-593.
220. Mudo G., Belluardo N., Mauro A., Fuxe K. Acute intermittent nicotine treatment induces fibroblast growth factor-2 in the subventricular zone of the adult rat brain and enhances neuronal precursor cell proliferation. Neuroscience 2007, 145:470-483.
221. Musazzi L., Cattaneo A., Tardito D., Barbon A., Gennarelli M., Barlati S., Racagni G., Popoli M. Early raise of BDNF in hippocampus suggests induction of posttranscriptional mechanisms by antidepressants. BMC Neuroscience 2009, 10:48.
222. Navailles S., Hof P.R., Schmauss C. Antidepressant drug-induced stimulation of mouse hippocampal neurogenesis is age-dependent and altered by early life stress. Journal of Comparative Neurology 2008, 509:372-381.
223. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron 2002, 34:13-25.
224. Nettles K.W., Pesold C., Goldman M.B. Influence of the ventral hippocampal formation on plasma vasopressin, hypothalamic-pituitary-adrenal axis, and behavioral responses to novel acoustic stress. Brain Research 2000, 858:181-190.
225. Neumaier J.F., Edwards E., Plotsky P.M. 5-HT(1B) mrna regulation in two animal models of altered stress reactivity. Biological Psychiatry 2002, 51:902-908.
226. Neumeister A., Bain E., Nugent A.C., Carson R.E., Bonne O., Luckenbaugh D.A., Eckelman W., Herscovitch P., Charney D.S., Drevets W.C. Reduced serotonin type 1A receptor binding in panic disorder. Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2004, 24:589-591.
227. Neumeister A., Konstantinidis A., Stastny J., Schwarz M.J., Vitouch O., Willeit M., Praschak-Rieder N., Zach J., de Zwaan M., Bondy B., Ackenheil M., Kasper S. Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Archives of General Psychiatry 2002, 59:613-620.
228. Nibuya M., Morinobu S., Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. Journal of Neuroscience: The Official Journal of the Society for Neuroscience 1995, 15:7539-7547.
229. Olivier J.D., Van Der Hart M.G., Van Swelm R.P., Dederen P.J., Homberg J.R., Cremers T., Deen P.M., Cuppen E., Cools A.R., Ellenbroek B.A. A study in male and female 5-HT transporter knockout rats: an animal model for anxiety and depression disorders. Neuroscience 2008, 152:573-584.
230. Overstreet D.H. The flinders sensitive line rats: a genetic animal model of depression. Neuroscience and Biobehavioral Reviews 1993, 17:51-68.
231. Paizanis E., Renoir T., Lelievre V., Saurini F., Melfort M., Gabriel C., Barden N., Mocaer E., Hamon M., Lanfumey L. Behavioural and neuroplastic effects of the new-generation antidepressant agomelatine compared to fluoxetine in glucocorticoid receptor-impaired mice. The International Journal of Neuropsychopharmacology/Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum 2010, 13:759-774.
232. Parihar V.K., Hattiangady B., Kuruba R., Shuai B., Shetty A.K. Predictable chronic mild stress improves mood, hippocampal neurogenesis and memory. Molecular Psychiatry 2011, 16:171-183.
233. Park J.H., Enikolopov G. Transient elevation of adult hippocampal neurogenesis after dopamine depletion. Experimental Neurology 2010, 222:267-276.
234. Pazos A., Probst A., Palacios J.M. Serotonin receptors in the human brain - IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience 1987, 21:123-139.
235. Pechnick R.N., Zonis S., Wawrowsky K., Cosgayon R., Farrokhi C., Lacayo L., Chesnokova V. Antidepressants stimulate hippocampal neurogenesis by inhibiting p21 expression in the subgranular zone of the hipppocampus. PLoS ONE 2011, 6:e27290.
236. Pentkowski N.S., Blanchard D.C., Lever C., Litvin Y., Blanchard R.J. Effects of lesions to the dorsal and ventral hippocampus on defensive behaviors in rats. European Journal of Neuroscience 2006, 23:2185-2196.
237. Perera T.D., Coplan J.D., Lisanby S.H., Lipira C.M., Arif M., Carpio C., Spitzer G., Santarelli L., Scharf B., Hen R., Rosoklija G., Sackeim H.A., Dwork A.J. Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates. Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2007, 27:4894-4901.
238. Perera T.D., Dwork A.J., Keegan K.A., Thirumangalakudi L., Lipira C.M., Joyce N., Lange C., Higley J.D., Rosoklija G., Hen R., Sackeim H.A., Coplan J.D. Necessity of hippocampal neurogenesis for the therapeutic action of antidepressants in adult nonhuman primates. PLoS ONE 2011, 6:e17600.
239. Petrik D., Lagace D.C., Eisch A.J. The neurogenesis hypothesis of affective and anxiety disorders: are we mistaking the scaffolding for the buildingα. Neuropharmacology 2012, 62:21-34.
240. Peyron C., Petit J.M., Rampon C., Jouvet M., Luppi P.H. Forebrain afferents to the rat dorsal raphe nucleus demonstrated by retrograde and anterograde tracing methods. Neuroscience 1998, 82:443-468.
241. Pitchot W., Hansenne M., Pinto E., Reggers J., Fuchs S., Ansseau M. 5-Hydroxytryptamine 1A receptors, major depression, and suicidal behavior. Biological Psychiatry 2005, 58:854-858.
242. Pitychoutis P.M., Griva E., Ioannou K., Tsitsilonis O.E., Papadopoulou-Daifoti Z. Chronic antidepressant treatment exerts sexually dimorphic immunomodulatory effects in an experimental model of major depression: do females lack an advantageα. The International Journal of Neuropsychopharmacology/official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum 2009, 12:1157-1163.
243. Pollak D.D., Monje F.J., Zuckerman L., Denny C.A., Drew M.R., Kandel E.R. An animal model of a behavioral intervention for depression. Neuron 2008, 60:149-161.
244. Possel P. Can Beck's theory of depression and the response style theory be integratedα. Journal of Counseling Psychology 2011, 58:618-629.
245. Price J.L., Drevets W.C. Neurocircuitry of mood disorders. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2010, 35:192-216.
246. Pruessner M., Hellhammer D.H., Pruessner J.C., Lupien S.J. Self-reported depressive symptoms and stress levels in healthy young men: associations with the cortisol response to awakening. Psychosomatic Medicine 2003, 65:92-99.
247. Pucilowski O., Overstreet D.H., Rezvani A.H., Janowsky D.S. Chronic mild stress-induced anhedonia: greater effect in a genetic rat model of depression. Physiology & Behavior 1993, 54:1215-1220.
248. Qi X., Lin W., Li J., Pan Y., Wang W. The depressive-like behaviors are correlated with decreased phosphorylation of mitogen-activated protein kinases in rat brain following chronic forced swim stress. Behavioural Brain Research 2006, 175:233-240.
249. Rabiner E.A., Bhagwagar Z., Gunn R.N., Cowen P.J., Grasby P.M. Preferential 5-HT1A autoreceptor occupancy by pindolol is attenuated in depressed patients: effect of treatment or an endophenotype of depressionα. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2004, 29:1688-1698.
250. Rainer Q., Xia L., Guilloux J.P., Gabriel C., Mocaer E., Hen R., Enhamre E., Gardier A.M., David D.J. Beneficial behavioural and neurogenic effects of agomelatine in a model of depression/anxiety. International Journal of Neuropsychopharmacology 2011, 1-15.
251. Raison C.L., Miller A.H. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. American Journal of Psychiatry 2003, 160:1554-1565.
252. Rasheed N., Tyagi E., Ahmad A., Siripurapu K.B., Lahiri S., Shukla R., Palit G. Involvement of monoamines and proinflammatory cytokines in mediating the anti-stress effects of Panax quinquefolium. Journal of Ethnopharmacology 2008, 117:257-262.
253. Renthal W., Maze I., Krishnan V., Covington H.E., Xiao G., Kumar A., Russo S.J., Graham A., Tsankova N., Kippin T.E., Kerstetter K.A., Neve R.L., Haggarty S.J., McKinsey T.A., Bassel-Duby R., Olson E.N., Nestler E.J. Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli. Neuron 2007, 56:517-529.
254. Ressler K.J., Nemeroff C.B. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety 2000, 12(Suppl. 1):2-19.
255. Riad M., Rbah L., Verdurand M., Aznavour N., Zimmer L., Descarries L. Unchanged density of 5-HT(1A) autoreceptors on the plasma membrane of nucleus raphe dorsalis neurons in rats chronically treated with fluoxetine. Neuroscience 2008, 151:692-700.
256. Riad M., Zimmer L., Rbah L., Watkins K.C., Hamon M., Descarries L. Acute treatment with the antidepressant fluoxetine internalizes 5-HT1A autoreceptors and reduces the in vivo binding of the PET radioligand [18F]MPPF in the nucleus raphe dorsalis of rat. Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2004, 24:5420-5426.
257. Richardson-Jones J.W., Craige C.P., Guiard B.P., Stephen A., Metzger K.L., Kung H.F., Gardier A.M., Dranovsky A., David D.J., Beck S.G., Hen R., Leonardo E.D. 5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants. Neuron 2010, 65:40-52.
258. Richell R.A., Deakin J.F., Anderson I.M. Effect of acute tryptophan depletion on the response to controllable and uncontrollable noise stress. Biological Psychiatry 2005, 57:295-300.
259. Rizk P., Salazar J., Raisman-Vozari R., Marien M., Ruberg M., Colpaert F., Debeir T. The alpha2-adrenoceptor antagonist dexefaroxan enhances hippocampal neurogenesis by increasing the survival and differentiation of new granule cells. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2006, 31:1146-1157.
260. Roman O., Seres J., Pometlova M., Jurcovicova J. Neuroendocrine or behavioral effects of acute or chronic emotional stress in Wistar Kyoto (WKY) and spontaneously hypertensive (SHR) rats. Endocrine Regulations 2004, 38:151-155.
261. Rosa-Neto P., Diksic M., Okazawa H., Leyton M., Ghadirian N., Mzengeza S., Nakai A., Debonnel G., Blier P., Benkelfat C. Measurement of brain regional alpha-[11C]methyl-l-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression. Archives of General Psychiatry 2004, 61:556-563.
262. Rossi C., Angelucci A., Costantin L., Braschi C., Mazzantini M., Babbini F., Fabbri M.E., Tessarollo L., Maffei L., Berardi N., Caleo M. Brain-derived neurotrophic factor (BDNF) is required for the enhancement of hippocampal neurogenesis following environmental enrichment. European Journal of Neuroscience 2006, 24:1850-1856.
263. Rouchet N., Waroux O., Lamy C., Massotte L., Scuvee-Moreau J., Liegeois J.-F., Seutin V. SK channel blockade promotes burst firing in dorsal raphe serotonergic neurons. European Journal of Neuroscience 2008, 28:1108-1115.
264. Russo S.J., Murrough J.W., Han M.-H., Charney D.S., Nestler E.J. Neurobiology of resilience. Nature Neuroscience 2012, 15:1475-1484.
265. Sahay A., Scobie K.N., Hill A.S., O'Carroll C.M., Kheirbek M.A., Burghardt N.S., Fenton A.A., Dranovsky A., Hen R. Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation. Nature 2011, 472:U466-U539.
266. Sairanen M., Lucas G., Ernfors P., Castren M., Castren E. Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2005, 25:1089-1094.
267. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., Weisstaub N., Lee J., Duman R., Arancio O., Belzung C., Hen R. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003, 301:805-809.
268. Sapolsky R. Taming stress. Scientific American 2003, 289:86-95.
269. Sargent P.A., Kjaer K.H., Bench C.J., Rabiner E.A., Messa C., Meyer J., Gunn R.N., Grasby P.M., Cowen P.J. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Archives of General Psychiatry 2000, 57:174-180.
270. Scharfman H., Goodman J., Macleod A., Phani S., Antonelli C., Croll S. Increased neurogenesis and the ectopic granule cells after intrahippocampal BDNF infusion in adult rats. Experimental Neurology 2005, 192:348-356.
271. Schloesser R.J., Jimenez D.V., Hardy N.F., Paredes D., Catlow B.J., Manji H.K., McKay R.D., Martinowich K. Atrophy of pyramidal neurons and increased stress-induced glutamate levels in CA3 following chronic suppression of adult neurogenesis. Brain Structure & Function 2013, http://www.ncbi.nlm.nih.gov/pubmed/23483239.
272. Schloesser R.J., Manji H.K., Martinowich K. Suppression of adult neurogenesis leads to an increased hypothalamo-pituitary-adrenal axis response. Neuroreport 2009, 20:553-557.
273. Schmidt H.D., Duman R.S. Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2010, 35:2378-2391.
274. Schultz W. Multiple dopamine functions at different time courses. Annual review of neuroscience 2007, 30:259-288.
275. Schweimer J.V., Ungless M.A. Phasic responses in dorsal raphe serotonin neurons to noxious stimuli. Neuroscience 2010, 171:1209-1215.
276. Sharp T., Boothman L., Raley J., Queree P. Important messages in the 'post': recent discoveries in 5-HT neurone feedback control. Trends in Pharmacological Sciences 2007, 28:629-636.
277. Sheikh N., Ahmad A., Siripurapu K.B., Kuchibhotla V.K., Singh S., Palit G. Effect of Bacopa monniera on stress induced changes in plasma corticosterone and brain monoamines in rats. Journal of Ethnopharmacology 2007, 111:671-676.
278. Shi S.S., Shao S.H., Yuan B.P., Pan F., Li Z.L. Acute stress and chronic stress change brain-derived neurotrophic factor (BDNF) and tyrosine kinase-coupled receptor (TrkB) expression in both young and aged rat hippocampus. Yonsei Medical Journal 2010, 51:661-671.
279. Shima K., Nakahama H., Yamamoto M. Firing properties of two types of nucleus raphe dorsalis neurons during the sleep-waking cycle and their responses to sensory stimuli. Brain Research 1986, 399:317-326.
280. Shin M.H., Mavila N., Wang W.H., Vega Alvarez S., Hall M.C., Andrisani O.M. Time-dependent activation of Phox2a by the cyclic AMP pathway modulates onset and duration of p27Kip1 transcription. Molecular and Cellular Biology 2009, 29:4878-4890.
281. Shirayama Y., Chen A.C., Nakagawa S., Russell D.S., Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2002, 22:3251-3261.
282. Silberg J., Pickles A., Rutter M., Hewitt J., Simonoff E., Maes H., Carbonneau R., Murrelle L., Foley D., Eaves L. The influence of genetic factors and life stress on depression among adolescent girls. Archives of General Psychiatry 1999, 56:225-232.
283. Silverman L.H. Psychoanalytic theory "the reports of my death are greatly exaggerated". American Psychologist 1976, 31:621-637.
284. Smith M.A., Makino S., Kim S.Y., Kvetnansky R. Stress increases brain-derived neurotropic factor messenger ribonucleic acid in the hypothalamus and pituitary. Endocrinology 1995, 136:3743-3750.
285. Smith M.A., Makino S., Kvetnansky R., Post R.M. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. Journal of Neuroscience: The Official Journal of the Society for Neuroscience 1995, 15:1768-1777.
286. Snyder J.S., Ferrante S.C., Cameron H.A. Late maturation of adult-born neurons in the temporal dentate gyrus. PLoS ONE 2012, 7:e48757.
287. Snyder J.S., Soumier A., Brewer M., Pickel J., Cameron H.A. Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature 2011, 476:458-461.
288. Song C., Leonard B.E. The olfactory bulbectomised rat as a model of depression. Neuroscience and Biobehavioral Reviews 2005, 29:627-647.
289. Spalding K.L., Bergmann O., Alkass K., Bernard S., Salehpour M., Huttner H.B., Bostrom E., Westerlund I., Vial C., Buchholz B.A., Possnert G., Mash D.C., Druid H., Frisen J. Dynamics of hippocampal neurogenesis in adult humans. Cell 2013, 153:1219-1227.
290. Steciuk M., Kram M., Kramer G.L., Petty F. Acute stress does not alter 5-HT1A receptor density. Progress in Neuropsychopharmacology & Biological Psychiatry 2000, 24:155-161.
291. Steinbusch H.W. Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals. Neuroscience 1981, 6:557-618.
292. Steiner M.A., Wanisch K., Monory K., Marsicano G., Borroni E., Bachli H., Holsboer F., Lutz B., Wotjak C.T. Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice. Pharmacogenomics Journal 2008, 8:196-208.
293. Stockmeier C.A., Shapiro L.A., Dilley G.E., Kolli T.N., Friedman L., Rajkowska G. Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. Journal of Neuroscience: The Official Journal of the Society for Neuroscience 1998, 18:7394-7401.
294. Sun Y., Jin K., Childs J.T., Xie L., Mao X.O., Greenberg D.A. Vascular endothelial growth factor-B (VEGFB) stimulates neurogenesis: evidence from knockout mice and growth factor administration. Developmental Biology 2006, 289:329-335.
295. Surget A., Saxe M., Leman S., Ibarguen-Vargas Y., Chalon S., Griebel G., Hen R., Belzung C. Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal. Biological Psychiatry 2008, 64:293-301.
296. Surget A., Tanti A., Leonardo E.D., Laugeray A., Rainer Q., Touma C., Palme R., Griebel G., Ibarguen-Vargas Y., Hen R., Belzung C. Antidepressants recruit new neurons to improve stress response regulation. Molecular Psychiatry 2011, 16:1177-1188.
297. Swiergiel A.H., Leskov I.L., Dunn A.J. Effects of chronic and acute stressors and CRF on depression-like behavior in mice. Behavioural Brain Research 2008, 186:32-40.
298. Takase L.F., Nogueira M.I., Baratta M., Bland S.T., Watkins L.R., Maier S.F., Fornal C.A., Jacobs B.L. Inescapable shock activates serotonergic neurons in all raphe nuclei of rat. Behavioural Brain Research 2004, 153:233-239.
299. Taliaz D., Stall N., Dar D.E., Zangen A. Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis. Molecular Psychiatry 2010, 15:80-92.
300. Tanti A., Westphal W.P., Girault V., Brizard B., Devers S., Leguisquet A.M., Surget A., Belzung C. Region-dependent and stage-specific effects of stress, environmental enrichment, and antidepressant treatment on hippocampal neurogenesis. Hippocampus 2013.
301. Trulson M.E., Jacobs B.L. Raphe unit activity in freely moving cats: correlation with level of behavioral arousal. Brain Research 1979, 163:135-150.
302. Trulson M.E., Preussler D.W. Dopamine-containing ventral tegmental area neurons in freely moving cats: activity during the sleep-waking cycle and effects of stress. Experimental Neurology 1984, 83:367-377.
303. Tsankova N., Renthal W., Kumar A., Nestler E.J. Epigenetic regulation in psychiatric disorders. Nature reviews. Neuroscience 2007, 8:355-367.
304. Ueyama E., Ukai S., Ogawa A., Yamamoto M., Kawaguchi S., Ishii R., Shinosaki K. Chronic repetitive transcranial magnetic stimulation increases hippocampal neurogenesis in rats. Psychiatry and Clinical Neurosciences 2011, 65:77-81.
305. Valente M.M., Bortolotto V., Cuccurazzu B., Ubezio F., Meneghini V., Francese M.T., Canonico P.L., Grilli M. alpha2delta ligands act as positive modulators of adult hippocampal neurogenesis and prevent depression-like behavior induced by chronic restraint stress. Molecular Pharmacology 2012, 82:271-280.
306. Valverde O., Torrens M. CB1 receptor-deficient mice as a model for depression. Neuroscience 2012, 204:193-206.
307. van Praag H. Serotonin-related, anxiety/aggression-driven, stressor-precipitated depression. A psycho-biological hypothesis. European Psychiatry: Journal of the Association of European Psychiatrists 1996, 11:57-67.
308. van Praag H.M. Can stress cause depressionα. Progress in Neuropsychopharmacology & Biological Psychiatry 2004, 28:891-907.
309. van Strien N.M., Cappaert N.L., Witter M.P. The anatomy of memory: an interactive overview of the parahippocampal-hippocampal network. Nature reviews. Neuroscience 2009, 10:272-282.
310. Vazquez-Palacios G., Bonilla-Jaime H., Velazquez-Moctezuma J. Antidepressant effects of nicotine and fluoxetine in an animal model of depression induced by neonatal treatment with clomipramine. Progress in Neuropsychopharmacology & Biological Psychiatry 2005, 29:39-46.
311. Veena J., Rao B.S., Srikumar B.N. Regulation of adult neurogenesis in the hippocampus by stress, acetylcholine and dopamine. Journal of Natural Science, Biology, and Medicine 2011, 2:26-37.
312. Veena J., Srikumar B.N., Mahati K., Bhagya V., Raju T.R., Shankaranarayana Rao B.S. Enriched environment restores hippocampal cell proliferation and ameliorates cognitive deficits in chronically stressed rats. Journal of Neuroscience Research 2009, 87:831-843.
313. Veldhuis H.D., De Korte C.C., De Kloet E.R. Glucocorticoids facilitate the retention of acquired immobility during forced swimming. European Journal of Pharmacology 1985, 115:211-217.
314. Vicentic A., Francis D., Moffett M., Lakatos A., Rogge G., Hubert G.W., Harley J., Kuhar M.J. Maternal separation alters serotonergic transporter densities and serotonergic 1A receptors in rat brain. Neuroscience 2006, 140:355-365.
315. Vogel G., Neill D., Hagler M., Kors D. A new animal model of endogenous depression: a summary of present findings. Neuroscience and Biobehavioral Reviews 1990, 14:85-91.
316. Vollmayr B., Simonis C., Weber S., Gass P., Henn F. Reduced cell proliferation in the dentate gyrus is not correlated with the development of learned helplessness. Biological Psychiatry 2003, 54:1035-1040.
317. Walletschek H., Raab A. Spontaneous activity of dorsal raphe neurons during defensive and offensive encounters in the tree-shrew. Physiology & Behavior 1982, 28:697-705.
318. Wang J.W., David D.J., Monckton J.E., Battaglia F., Hen R. Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells. Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2008, 28:1374-1384.
319. Warner-Schmidt J.L., Duman R.S. VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:4647-4652.
320. Waterhouse E.G., An J.J., Orefice L.L., Baydyuk M., Liao G.Y., Zheng K., Lu B., Xu B. BDNF promotes differentiation and maturation of adult-born neurons through GABAergic transmission. Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2012, 32:14318-14330.
321. Weiss J.M., Cierpial M.A., West C.H. Selective breeding of rats for high and low motor activity in a swim test: toward a new animal model of depression. Pharmacology, Biochemistry, and Behavior 1998, 61:49-66.
322. Wilber A.A., Walker A.G., Southwood C.J., Farrell M.R., Lin G.L., Rebec G.V., Wellman C.L. Chronic stress alters neural activity in medial prefrontal cortex during retrieval of extinction. Neuroscience 2011, 174:115-131.
323. Wilkinson L.O., Jacobs B.L. Lack of response of serotonergic neurons in the dorsal raphe nucleus of freely moving cats to stressful stimuli. Experimental Neurology 1988, 101:445-457.
324. Willner P. Animal models of depression: an overview. Pharmacology & Therapeutics 1990, 45:425-455.
325. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology 1997, 134:319-329.
326. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005, 52:90-110.
327. Willner P., Muscat R., Papp M. Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neuroscience and Biobehavioral Reviews 1992, 16:525-534.
328. Willner P., Towell A., Sampson D., Sophokleous S., Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology 1987, 93:358-364.
329. Wilson M.A., Molliver M.E. The organization of serotonergic projections to cerebral cortex in primates: retrograde transport studies. Neuroscience 1991, 44:555-570.
330. Wong E.Y., Herbert J. The corticoid environment: a determining factor for neural progenitors' survival in the adult hippocampus. European Journal of Neuroscience 2004, 20:2491-2498.
331. Wong E.Y., Herbert J. Raised circulating corticosterone inhibits neuronal differentiation of progenitor cells in the adult hippocampus. Neuroscience 2006, 137:83-92.
332. Yang P., Arnold S.A., Habas A., Hetman M., Hagg T. Ciliary neurotrophic factor mediates dopamine D2 receptor-induced CNS neurogenesis in adult mice. Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2008, 28:2231-2241.
333. Ye W., Mairet-Coello G., Pasoreck E., Dicicco-Bloom E. Patterns of p57Kip2 expression in embryonic rat brain suggest roles in progenitor cell cycle exit and neuronal differentiation. Developmental neurobiology 2009, 69:1-21.
334. Yi L.T., Li J.M., Li Y.C., Pan Y., Xu Q., Kong L.D. Antidepressant-like behavioral and neurochemical effects of the citrus-associated chemical apigenin. Life Sciences 2008, 82:741-751.
335. Zalsman G., Huang Y.Y., Oquendo M.A., Burke A.K., Hu X.Z., Brent D.A., Ellis S.P., Goldman D., Mann J.J. Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. American Journal of Psychiatry 2006, 163:1588-1593.
336. Zhang T.Y., Meaney M.J. Epigenetics and the environmental regulation of the genome and its function. Annual Review of Psychology 2010, 61:439-466. C431-433.
337. Ziabreva I., Poeggel G., Schnabel R., Braun K. Separation-induced receptor changes in the hippocampus and amygdala of Octodon degus: influence of maternal vocalizations. Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2003, 23:5329-5336.